Celgene

Celgene Corporation: Today's Featured Drugs Winner
The Street
Sat, 09/15/12 - 09:28 am
Celgene
Pipeline Progress at CELG, Shares Up
Yahoo/Zacks
Sat, 09/8/12 - 10:37 am
PALACE-2
PALACE-3
Celgene
psoriatic arthritis
Celgene Arthritis Treatment Meets Primary Goals in Study
NASDAQ.com
Fri, 09/7/12 - 12:14 pm
Celgene
apremilast
psoriatic arthritis
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
Celgene may purchase $4.9M in additional shares of Globelmmune
The Fly on the Wall
Mon, 08/20/12 - 10:28 am
Celgene
GlobeImmune
M&A
4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
Seeking Alpha
Sat, 08/18/12 - 03:34 pm
Amgen
Celgene
Alexion
Regeneron
3 Innovative Biotech Stocks To Consider Today
Seeking Alpha
Mon, 08/13/12 - 01:36 pm
Celgene
OncoSec
Onyx
Bayer
Arqule
Pfizer Eyes Kevetrin?
Seeking Alpha
Mon, 08/13/12 - 12:02 pm
Pfizer
Kevetrin
Celgene
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
What To Expect For The Future Of Celgene
Seeking Alpha
Mon, 07/30/12 - 10:58 am
Celgene
Biotechs In Motion As New Drug Pipeline Brims
investors.com
Sun, 07/29/12 - 01:00 pm
Amgen
Celgene
Biogen Idec
Gilead Sciences
Regeneron
Vertex Pharmaceuticals
Alexion
Arena Pharmaceuticals
ONYX Pharmaceuticals
United Therapeutics
Pay Attention to These Biotechs
Yahoo/TheStreet.com
Fri, 07/27/12 - 12:50 pm
Gilead
Amgen
Celgene
28 Drugs Facing FDA Approval in 2012-2013
TheStreet.com
Tue, 07/24/12 - 09:52 am
FDA
Amarin
Horizon Pharma
Salix
Progenics Pharmaceuticals
Regeneron
Sanofi
Talon Therapeutics
Gilead
Pfizer
Ironwood
Celgene
NPS Pharmaceuticals
Navidea Biopharmaceuticals
Celgene Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Mon, 07/23/12 - 10:13 pm
earnings
Celgene
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com
Mon, 07/16/12 - 12:16 pm
Eli Lilly
Verastem
Celgene
QLT
Amylin
Celgene's Treading Into Open Water
Motley Fool
Sun, 07/15/12 - 11:41 am
Celgene
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
Mon, 07/9/12 - 10:12 am
M&A
Human Genome Sciences
Celgene
Amylin
GSK
Novo Nordisk
Exclusive: Celgene mulls Human Genome Sciences bid - source
Reuters
Sat, 07/7/12 - 11:27 am
Celgene
Human Genome Sciences
M&A

Pages